Adverse events with COVID-19 vaccination (precaution dose) among the elderly population aged 60 years and above in South India

Authors

  • Anju Damu Ade Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, Tirupati, Andhra Pradesh, India
  • Chandrashekhar Vallepalli Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, Tirupati, Andhra Pradesh, India
  • Visweswara Rao Guthi Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, Tirupati, Andhra Pradesh, India
  • T. V. D. Prathyusha Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, Tirupati, Andhra Pradesh, India
  • K. Nagraj Department of Community Medicine, SVIMS-Sri Padmavathi Medical College for Women, Tirupati, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20231298

Keywords:

COVID-19 vaccination, Precaution dose, Adverse events following immunization, Elderly population

Abstract

Background: India started administering the precaution dose or the Booster dose of COVID vaccine from 10 January 2022 to comorbid people aged 60 and above. To identify the adverse events with COVID-19 vaccination (precaution dose) among the elderly population aged 60 years and above. To determine the association between adverse reactions and sociodemographic factors, morbidity profile and previous history of COVID 19.

Methods: This cross-sectional study was undertaken at COVID- 19 vaccination centre, of SVIMS, Tirupati. AP from January 2022 to July 2022. Data was collected by interviewing the study subjects. Study respondents who received COVID-19 vaccine were observed for a period of 30 minutes and after 48 hours, study participants were contacted through telephone to find out any vaccine related adverse effects.

Results: Overall, 676 of 60 years or older received their precaution dose. Majority of the respondents were in 60-70 years age group (60.8%) males (n=397, 58.7%) were higher than females (n=279,41.3%). Out of 676, 34 (5.0 %) participants reported adverse effects after 1st or 2nd dose. With regard to precaution dose, only 43 (6.4%) reported adverse events within the 30 minutes of receiving COVID-19 vaccine. While 54 (8.0%) reported adverse events in last 48 hours after receiving COVID-19 vaccine (precaution dose). Spectrum of symptoms reported were fever, anxiety, dizziness/giddiness, body pains, headache, nausea, pain at injection site, pain in abdomen, swelling at injection site, rash.

Conclusions: Only 43 (6.4%) reported adverse events within the 30 minutes of receiving COVID-19 vaccine while 54 (8.0%) reported adverse events in last 48 hours after receiving COVID-19 vaccine(precaution dose).There were no reports of serious adverse effects.

References

Annual Report 2020-2021. Ministry of health and family welfare, Government of India, p-219. Available at: https://main.mohfw.gov.in/sites/ default/files/Annual%20Report%202020-21%20 English.pdf. Accessed on 22nd February 2023.

National Vaccine Policy, ministry of health and family welfare, GOI, 2011. Available at https://main.mohfw.gov.in/sites/default/files/108481119000.pdf. ed on Accessed on 22nd February 2023.

United Nations. World Population Prospects: The 2015 Revision. United Nations Department of Economic and Social Affairs Population Division. Geneva: 2015.

Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using Opens SAFELY. Nature. 2020;584:430-6.

Health Advisory for Elderly Population of India during COVID19. Available at: Advisory forElderlyPopulation.pdf (mohfw.gov.in). Accessed on 22nd February 2023.

India to start COVID-19 precaution vaccine doses tomorrow: Check eligibility, gap between doses, how to register here (firstpost.com). Available at https://www.firstpost.com. Accessed on 22nd February 2023.

Adverse Events Following Immunization (AEFI), WHO. Available at https://vaccine-safety-training.org/adverse-events-classification.html. Accessed on 22nd February 2023.

COVID-19 Risks and Vaccine Information for Older Adults Older Adults Risks and Vaccine Information. CDC. Available at https://www.cdc.gov/aging/ covid19/index.html. Accessed on 22nd February 2023.

Auster O, Finkel U, Dagan N. Short-term adverse events after the third dose of the BNT162b2 mRNA COVID-19 vaccine in adults 60 years or older. JAMA Netw Open. 2022;5(4):e227657.

Chaudhary C, Singh M, Khan MNA, Anand BK, Saini S. Adverse events following immunization against COVID-19 among healthcare workers: An observational study in Haryana, India. Asian J Med Sci. 202;13(3):23-9.

Kundawar A, Guralwar CO, Sontakke S. Study of Adverse Events following COVID-19 Vaccination: A cross-sectional Survey in India. J Assoc Physicians India. 2022;70(7):11-2.

Mahapatra S, Nagpal R, Marya CM, Taneja P, Kataria S. Adverse events occurring post-covid-19 vaccination among healthcare professionals-A mixed method study. Int Immuno pharmacol. 2021;100:108136.

Kamal D, Thakur V, Nath N, Malhotra T, Gupta A, Batlish R. Adverse events following ChAdOx1 nCoV-19 Vaccine (COVISHIELD) amongst health care workers: A prospective observational study. Med J Armed Forces India. 2021;77(Suppl 2):S283-S288.

Bhandari A, Tiwari SPS, Rathore M, Sharma L, Jain S. Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India. Geriatric Care. 2022;7(4).9908.

Arora G, Taneja J, Bhardwaj P. Adverse events and breakthrough infections associated withCOVID‐19 vaccination in the Indian population. J Med Virol. 2022;94:3147‐54.

Jayadevan R, Shenoy R. Survey of symptoms following COVID-19 vaccination in India. medRxiv. 2021. Available from: https://www. medrxiv.org/content/10.1101/2021.02.08.21251366v1. Accessed on 22nd February 2023..

Parida SP, Sahu DP, Singh AK. Adverse events following immunization of COVID‐19 (Covaxin) vaccine at a tertiary care center of India. J Med Virol. 2022;94:2453‐2459.

Downloads

Published

2023-04-28

How to Cite

Ade, A. D., Vallepalli, C., Guthi, V. R., Prathyusha, T. V. D., & Nagraj, K. (2023). Adverse events with COVID-19 vaccination (precaution dose) among the elderly population aged 60 years and above in South India. International Journal Of Community Medicine And Public Health, 10(5), 1926–1932. https://doi.org/10.18203/2394-6040.ijcmph20231298

Issue

Section

Original Research Articles